---
title: "前沿生物-U (688221.SH) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/688221.SH/norm.md"
symbol: "688221.SH"
name: "前沿生物-U"
parent: "https://longbridge.com/zh-HK/quote/688221.SH.md"
datetime: "2026-05-20T10:19:33.460Z"
locales:
  - [en](https://longbridge.com/en/quote/688221.SH/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688221.SH/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688221.SH/norm.md)
---

# 前沿生物-U (688221.SH) — 財務報表

## 損益表 (CNY)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | 0.6100 | -0.2892 | -0.1706 | -0.1396 | -0.1200 |
| ROE | 91.64% | -46.60% | -24.67% | -19.89% | -15.77% |
| 營業收入 | 297.13M | 20.01M | 44.73M | 30.31M | 28.33M |
| 凈利潤 | 227.39M | -108.24M | -62.46M | -53.23M | -44.12M |
| 營業利潤 | 225.90M | -107.60M | -50.26M | -54.47M | -44.44M |
| 毛利率 | 94.01% | 10.51% | 40.09% | 29.31% | 32.47% |
| 凈利率 | 76.53% | -540.88% | -139.62% | -175.61% | -155.75% |
| 利潤含金量 | 103.68% | - | - | - | - |

## 資產負債表 (CNY)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 1.85B | 1.58B | 1.64B | 1.66B | 1.72B |
| 權益乘數 | 1.67 | 1.80 | 1.67 | 1.59 | 1.57 |
| 每股凈資產 | 2.96 | 2.34 | 2.62 | 2.79 | 2.93 |
| 資產周轉率 | 0.2195 | 0.0728 | 0.0775 | 0.0737 | 0.0699 |
| 現金及短投 | 729.72M | 713.14M | 692.14M | 727.26M | 746.10M |
| 存貨與應收 | 78.20M | 66.62M | 48.51M | 62.06M | 45.40M |
| 長期投資 | 417.38M | 423.23M | 429.36M | 409.62M | 392.85M |
| 凈債務 | -258.13M | -306.35M | -317.80M | -393.59M | -365.04M |

## 現金流量表 (CNY)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | 217.88M | -74.80M | -53.56M | -49.56M | -48.67M |
| 投資現金流 | -260.54M | 117.23M | -34.97M | 28.04M | 62.38M |
| 融資現金流 | 59.98M | 30.79M | 21.96M | -32.76M | -44.42M |
| 自由現金流 | -148.92M | 65.07M | -93.03M | 56.51M | -71.87M |
| 現金流充裕率 | 265.04% | -165.17% | -125.30% | -23.06% | -48.36% |
| 舉債與償債 | 142.26M | 72.29M | 72.79M | 177.77M | 39.00M |
| 資本支出 | -2.21M | -3.79M | -2.41M | -6.28M | -17.39M |